
Journal of Organic Chemistry p. 10088 - 10105 (2013)
Update date:2022-08-15
Topics:
Fer, Mickael J.
Olatunji, Samir
Bouhss, Ahmed
Calvet-Vitale, Sandrine
Gravier-Pelletier, Christine
A straightforward strategy for the synthesis of triazole-containing MraY inhibitors has been developed. It involves the sequential introduction of a terminal alkyne at the 5′ position of an uridine derivative and O-glycosylation with a protected aminoribose leading to an elaborated alkyne scaffold. An efficient Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) allowed the introduction of chemical diversity toward a small library of inhibitors.
View More
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
website:https://sdjingyuan.lookchem.com/
Contact:86-531-82687998
Address:Factory Building 11, Jinan Comprehensive free trade zone, Shandong, China
Contact:86-27-84888681
Address:Wuhan economic & technology development zone
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Doi:10.1002/ejic.201100725
(2011)Doi:10.1055/s-0034-1378906
(2014)Doi:10.1039/c1ob06216f
(2011)Doi:10.1039/c1ob06345f
(2011)Doi:10.1016/j.saa.2011.08.060
(2012)Doi:10.1007/s11164-011-0447-z
(2012)